Lyell Immunopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $340.1M
Liabilities Breakdown FY2025
Total Liabilities: $91.9M
Asset Breakdown
Total Assets: $340.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $60.2M | 17.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $34.8M | 10.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $245.1M | 72.1% |
Liabilities Breakdown
Total Liabilities: $91.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.9M | 3.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $89.0M | 96.9% |